AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 165 filers reported holding AKERO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,374,467 | +38.9% | 50,856 | +13.8% | 0.44% | +31.0% |
Q1 2023 | $1,709,725 | -41.7% | 44,687 | -16.5% | 0.34% | -44.6% |
Q4 2022 | $2,932,458 | +1.8% | 53,512 | -36.8% | 0.61% | -3.0% |
Q3 2022 | $2,881,000 | +46.4% | 84,607 | +32.3% | 0.63% | +34.0% |
Q3 2020 | $1,968,000 | – | 63,928 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |